does semaglutide cause thirst Ozempic (semaglutide) is a GLP-1 receptor agonist used for type 2 diabetes (and sometimes weight loss). Its side effects range from common GI symptoms to rare but serious risks. βΈ» π‘ Common Semaglutide Before and After: Real
Description
Transcatheter Mitral-Valve Repair in Patients with Heart Failure

Your providers guidance and your personal response to the medication should drive the decision

Tirzepatides cardiovascular outcomes trial (SURPASS-CVOT) is ongoing as of 2026, so this comparison may change once those results are published

This led Pfizer to focus on the development of a once-daily version of the drug, which showed early success in Phase I trials (NCT06567327 and NCT06568731)

The desire for independence from medication motivates many decisions

Data availability Individual participant data will be shared in data sets in a de-identified/anonymised format
